Science Current Events | Science News | Brightsurf.com
 

AIDS vaccine Current Events | AIDS vaccine News | 3

Sort By: Page Views | Date

Hope: An overlooked tool in the battle against HIV/AIDS
The links between HIV transmission and the degree to which people are able to adopt realistic plans to achieve future projects, in other words, hope, have been overlooked in policies to tackle HIV/AIDS. New research funded by the Economic and Social Research Council (ESRC) argues that hope is a powerful tool in the battle to stop the spread of... view more... (2008-08-11)

Pharmaceutical Interests Versus AIDS In Africa (p 89)
The appointment of Randall Tobias as the US Government's global AIDS co-ordinator is analysed in this week's editorial. Tobias will head up a $15 billion programme to tackle AIDS in the African and Caribbean countries most devastated by the pandemic, although sceptics point out that his lack of knowledge about Africa and his pharmaceutical... view more... (2003-07-09)

CHAVI announces international search for genes affecting HIV response
A pioneering collaboration among U.S., European and Australian researchers announced June 20, 2006, will seek to identify genetic differences in the way people respond to HIV.   view more (2006-06-20)

Majority of children vaccinated against hepatitis B not at increased risk of MS
The majority of children vaccinated against hepatitis B are not at an increased risk of developing multiple sclerosis (MS).   view more (2008-09-26)

Vaccinated infants well protected against severe pneumococcal infection in Norway
Pneumococcus is a bacterium that can cause serious illnesses in some young children, e.g. meningitis, blood poisoning and pneumonia. Most of those who become ill are previously healthy without any known predisposing factors. The bacterium is present in the nose of up to 80 - 90% of healthy young children.   view more (2008-07-10)

Could drug companies help win the fight against AIDS?
Drug companies could influence the fight against the AIDS epidemic by reducing the cost of HIV drugs in poor countries to zero, writes Donald Berwick in this week's BMJ.   view more (2002-01-23)

The Hunt for a Hepatitis C Vaccine is Under Way at Saint Louis University School of Medicine
Human clinical trials involving investigational vaccines to prevent Hepatitis C are rare. In the fall of 2003 there was a first-ever study at Saint Louis University Center for Vaccine Development, and an earlier small study at Johns Hopkins School of Medicine.   view more (2006-05-04)

Researchers induce HIV-neutralizing antibodies that recognize HIV-1 envelope protein, lipids
For the first time, researchers have experimentally induced antibodies that neutralize HIV-1 and simultaneously recognize both HIV-1 envelope protein and lipids.   view more (2009-09-02)

Researchers progress toward AIDS vaccine
Rutgers AIDS researchers Gail Ferstandig Arnold and Eddy Arnold may have turned a corner in their search for a HIV vaccine. In a paper just published in the Journal of Virology, the husband and wife duo and their colleagues report on their research progress.    view more (2009-03-13)

T cells activated to fight HIV basis for dendritic cell therapeutic vaccine
Having their immune system cells go through a laboratory version of boot camp may help patients win their battle against HIV.   view more (2006-08-14)

Scientist warns over pandemic flu vaccine 6-month time lag
New research published today (Monday April 27) from the University of Leicester and University Hospitals of Leicester NHS Trust warns of a six-month time lag before effective vaccines can be manufactured in the event of a pandemic flu outbreak.   view more (2009-04-28)

Innovative method for creating a human cytomegalovirus vaccine outlined
Each year, about 40,000 children are born infected with human cytomegalovirus, or CMV, and about 8,000 of these children suffer permanent disabilities due to the virus - almost one an hour.   view more (2006-08-01)

Identified main genetic variants involved in response to HIV
This international collaboration has been the largest ever to have taken place in a large scale study on genetic differences between patients infected by HIV, and is the first study of this kind in the field of infectious disease.   view more (2007-07-23)

OHSU researchers discover possible HIV therapy in an animal study
Researchers have published a new study this week suggesting an important component of the immune system damaged by AIDS can possibly be replaced.   view more (2006-06-09)

Ebola DNA vaccine produces immune responses in all fully vaccinated volunteers in Phase 1 trial
Vical Incorporated (Nasdaq:VICL) announced today that an Ebola vaccine candidate administered using Vical's proprietary DNA delivery technology was safe and well tolerated, and produced both antibody and T-cell Ebola-specific responses in all healthy volunteers who received the full 3 doses of vaccine.   view more (2006-02-22)

HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand.   view more (2009-09-24)

Flu news: Study in 8,475 young children points to a more effective influenza vaccine
An intranasal influenza vaccine proved to be more effective than the injectable influenza vaccine in children older than 6 months and younger than 5 years of age.   view more (2006-05-02)

Parents confused about seriousness of measles, mumps and rubella
Parents who don't allow their children to have the MMR vaccine think that measles, mumps and rubella are less serious diseases than parents whose children have been vaccinated. Also, parents of children who go unvaccinated are more likely to believe there is a link between the vaccine and autism and/or bowel disorders.   view more (2004-08-23)

UTMB researchers test new vaccine to fight multiple influenza strains
A universal vaccine effective against several strains of influenza has passed its first phase of testing, according to Dr. Christine Turley of the University of Texas at Galveston.   view more (2008-08-22)

Cancer vaccine one step closer
Andreea Ioan-Facsinay from Leiden University Medical Center has attached proteins from tumour cells to antibodies. With these she treated immune cells from a mouse. These treated cells were used to make a vaccine, which was shown to be effective in animal experiments. If the follow-up research is successful, vaccines against cancer will become... view more... (2003-02-14)
Sort By: Page Views | Date
© 2009 BrightSurf.com